As part of our gold sponsorship, James Miles will deliver a short talk during the event, focusing on how Hawk Biosystems is integrating multi-omics with spatial biology to enhance disease profiling and therapeutic response prediction. With our innovative QF-Pro® platform, we are advancing the ability to spatially quantify protein functions and interactions within the tumour microenvironment. This data-driven approach is proving invaluable in areas such as immuno-oncology, where precise molecular interactions are key to understanding patient responses to therapies. We look forward to showcasing how Hawk Biosystems is leveraging multi-omics technologies to improve clinical outcomes.